Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
D000818:Animals; D000951:Antigens, Neoplasm; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006649:Histocompatibility Antigens; D007110:Immunity, Active; D007114:Immunization; D007167:Immunotherapy; D007519:Isoantigens; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D008223:Lymphoma / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL / Q000276:immunology; D008979:Moloney murine leukemia virus; D009374:Neoplasms, Experimental / Q000628:therapy; D013154:Spleen / Q000276:immunology*; D014184:Transplantation, Homologous; D014412:Tumor Virus Infections / Q000628:therapy*
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D007519:Isoantigens; D003520:Cyclophosphamide